Surmodics earnings were -$19.9M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest SRDX earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$5.2M, up 42.7% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, SRDX reported annual earnings of -$11.5M, with 651.4% growth. The next SRDX earnings date is Jul 29, 2025.
On SRDX's earnings call on Invalid Date, Surmodics (NASDAQ: SRDX) reported Q1 2025 earnings per share (EPS) of -$0.36, up 1,900% year over year. Total SRDX earnings for the quarter were -$5.21 million. In the same quarter last year, Surmodics's earnings per share (EPS) was $0.02.
The next SRDX earnings call is Invalid Date. Add SRDX to your watchlist to be reminded of Surmodics's next earnings date.
What was SRDX's earnings growth in the past year?
As of Surmodics's earnings date in Invalid Date, Surmodics's earnings has grown year over year. SRDX earnings in the past year totalled -$19.86 million.
Is Surmodics profitable or losing money?
As of the last Surmodics earnings report, Surmodics is currently losing money. Surmodics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$19.86 million, a 247.12% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.